Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/10303
Title: NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes
Authors: Zdravkovic, Vladimir
Mladenovic, Vladimir
Colic M.
Banković D.
Lazic Z.
Petrovic, Marina
Simic Vukomanovic, Ivana
Knežević V.
Pantović M.
djukic, aleksandar
Zdravkovic, Nemanja
Journal: Kardiologia Polska
Issue Date: 27-May-2013
Abstract: Background and aim: N terminal-proB-type natriuretic peptide (NT-proBNP) is synthesised and secreted from the ventricular myocardium. This marker is known to be elevated in patients with acute coronary syndromes (ACS). We evaluated NT-proBNP as a significant diagnostic marker and an important independent predictor of short-term mortality (one month) in patients with ACS. Methods: NT-proBNP and cardiac troponin I (cTI) were assessed in 134 consecutive patients (median age 66 years, 73% male) hospitalised for ACS in a cardiological university department. The patients were classified into ST-elevation ACS (STE-ACS, n = 74) and non-ST-elevation ACS (NSTE-ACS, n = 60) groups based on the ECG findings on admission. Patients with Killip class ≥ II were excluded. Results: The serum level of NT-proBNP on admission was significantly higher (p < 0.0005), while there was no difference in cTI serum level in the NSTE-ACS patients compared to STE-ACS patients. There was a significant positive correlation between NT-proBNP and cTI in the NSTE-ACS (r = 0.338, p = 0.008) and STE-ACS (r = 0.441, p < 0.0005) patients. There was a significant difference in NT-proBNP (p < 0.0005) and cTI (p < 0.0005) serum level between ACS patients who died within 30 days or who survived after one month. The increased NT-proBNP level is the strongest predictor of mortality in ACS patients, also NT-proBNP cut-point level of 1,490 pg/mL is a significant independent predictor of mortality. Conclusions: We demonstrated the differences and the correlation in the secretion of NT-proBNP and cTI in patients with STE-ACS vs. NSTE-ACS. Our results provide evidence that NT-proBNP is a significant diagnostic marker and an important independent predictor of short-term mortality in patients with ACS. Copyright © Polskie Towarzystwo Kardiologiczne.
URI: https://scidar.kg.ac.rs/handle/123456789/10303
Type: Article
DOI: 10.5603/KP.2013.0093
ISSN: 00229032
SCOPUS: 84878934865
Appears in Collections:Faculty of Medical Sciences, Kragujevac
[ Google Scholar ]

Page views(s)

19

Downloads(s)

1

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access
29.86 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.